Anti-DRAK1 antibody
| 英文名称 | DRAK1 |
| 中文名称 | 丝氨酸/苏氨酸蛋白激酶17A/DAP凋亡诱导蛋白激酶1抗体 |
| 别 名 | DAP kinase-related apoptosis-inducing protein kinase 1; death-associated protein kinase-related 1; EC 2.7.11.1; Serine / threonine kinase 17a death associated protein kinase related 1; Serine/threonine kinase 17a; Serine/threonine protein kinase 17a; STK17 A; STK17A; ST17A_HUMAN. |
DATASHEET
Host:Rabbit
Target Protein:DRAK1
IR:Immunogen Range:45-150/414
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:9263
Swiss Prot:Q9UEE5
Source:KLH conjugated synthetic peptide derived from human DRAK1/STK17A:45-150/414
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:DRAK1 (DAP kinase-related apoptosis-inducing protein kinase 1) is a novel member of the ser/thr protein kinase family, which mediate apoptosis through their catalytic activities. The full-length cDNA encodes a deduced 414-amino acid protein with a molecular mass of 46.56 kD. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. DRAK1 messenger RNA appears to be ubiquitously expressed in human tissues. Overexpression of DRAK1 induces apoptosis. It has been shown in vitro that DRAK1 is capable of autophosphorylation and of phosphorylating the myosin light chain as an exogenous substrate, and that the noncatalytic C terminus is crucial for full kinase activity.
Size:100ul
Concentration:1mg/ml
Applications:ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
IF(1:100-500)
Cross Reactive Species:Human
Mouse
Rat
Chicken
Rabbit
.
For research use only. Not intended for diagnostic or therapeutic use.
好评度